Metropolis Healthcare Shares Garner Bullish Outlook Following Strong Q4 Performance
Market Analysts Maintain Bullish Stance Following a robust fourth-quarter performance for the 2026 fiscal year, leading brokerage firms Nuvama and Emkay have reaffirmed their bullish outlook on Metropolis Healthcare, India’s second-largest pathology laboratory chain. The company reported a 74 percent year-on-year surge in consolidated profit after tax, reaching Rs 50.96 crore, while revenue from operations…
